Galzin A M, Langer S Z
J Pharmacol Exp Ther. 1985 May;233(2):459-65.
Rabbit hypothalamic slices were prelabeled with [3H]norepinephrine and transmitter release elicited by electrical stimulation. In the presence of 10 microM cocaine and in a low Ca++ medium (0.65 mM), exposure for 8 min to exogenous dopamine (0.01-1 microM) inhibited, in a concentration-dependent manner, the electrically evoked release of [3H]norepinephrine. This inhibitory effect of dopamine on [3H]norepinephrine release was antagonized by the dopamine receptor antagonist S-sulpiride (1 microM), but remained unchanged in the presence of the alpha-2 adrenoceptor antagonists idazoxan (1 microM) or yohimbine (0.1 microM). These results indicate that, in a low Ca++ medium, exposure to dopamine decreased [3H]norepinephrine overflow in rabbit hypothalamic slices through the exclusive activation of presynaptic inhibitory dopamine receptors. M7 (5,6-dihydroxy-2-dimethylaminotetralin) is a potent agonist at central presynaptic dopamine autoreceptors and at peripheral alpha-2 adrenoceptors. Exposure to M7 in a normal Ca++ medium, inhibited in a concentration-dependent manner the electrically evoked release of [3H]norepinephrine without affecting the spontaneous outflow of radioactivity. The slope of the concentration-effect curve for these inhibitory effects of M7 was rather flat and the maximal inhibition obtained was 80%. The selective D2 receptor antagonist S-sulpiride (1 microM) failed to produce a significant shift to the right in the concentration-effect curve for the inhibitory effects of M7 on [3H]norepinephrine release. The preferential alpha-2 adrenoceptor antagonist yohimbine (0.1 microM) significantly antagonized the inhibition of [3H]norepinephrine release elicited by 0.01 microM M7, but not for higher concentrations of this aminotetraline.(ABSTRACT TRUNCATED AT 250 WORDS)
兔下丘脑切片预先用[3H]去甲肾上腺素标记,并通过电刺激引发递质释放。在存在10微摩尔可卡因和低钙(0.65毫摩尔)培养基的情况下,暴露于外源性多巴胺(0.01 - 1微摩尔)8分钟,以浓度依赖的方式抑制了电诱发的[3H]去甲肾上腺素释放。多巴胺对[3H]去甲肾上腺素释放的这种抑制作用被多巴胺受体拮抗剂S-舒必利(1微摩尔)拮抗,但在α-2肾上腺素能受体拮抗剂咪唑克生(1微摩尔)或育亨宾(0.1微摩尔)存在时保持不变。这些结果表明,在低钙培养基中,暴露于多巴胺通过突触前抑制性多巴胺受体的特异性激活降低了兔下丘脑切片中[3H]去甲肾上腺素的溢出。M7(5,6 - 二羟基 - 2 - 二甲基氨基四氢萘)是中枢突触前多巴胺自身受体和外周α-2肾上腺素能受体的强效激动剂。在正常钙培养基中暴露于M7,以浓度依赖的方式抑制了电诱发的[3H]去甲肾上腺素释放,而不影响放射性的自发流出。M7这些抑制作用的浓度 - 效应曲线斜率相当平缓,最大抑制率为80%。选择性D2受体拮抗剂S-舒必利(1微摩尔)未能使M7对[3H]去甲肾上腺素释放抑制作用的浓度 - 效应曲线显著右移。优先的α-2肾上腺素能受体拮抗剂育亨宾(0.1微摩尔)显著拮抗了0.01微摩尔M7引起的[3H]去甲肾上腺素释放抑制,但对该氨基四氢萘的更高浓度则无此作用。(摘要截短于250字)